Hirudo medicinalis: A vascular tissues for clear-cut angiogenesis studies?

Current Pharmaceutical Design

Volumn 10, Issue 16, 2004, Pages 1979-1988

  de Eguileor, Magda ^a   Tettamanti, Gianluca ^a   Grimaldi, Annalisa ^a   Perletti, Gianpaolo ^b   Congiu, Terenzio ^b   Rinaldi, Liliana ^a   Valvassori, Roberto ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b Department of Human Morphology ^*  (Italy)

Author keywords

Angiogenesis; Cytokines; Gene therapy; Leeches; VEGF

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; CYTOKINE; EPIDERMAL GROWTH FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR RECEPTOR; HIRUDIN; NAKED DNA; PLATELET DERIVED GROWTH FACTOR; PROTEOGLYCAN; RECOMBINANT GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; CLINICAL TRIAL; DNA VECTOR; DRUG RESEARCH; EXPERIMENTAL MODEL; GENE THERAPY; HEART MUSCLE ISCHEMIA; HUMAN; INVERTEBRATE; LIMB ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; VERTEBRATE; ANIMAL; DRUG EFFECT; LEECH; PHYSIOLOGY;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; ANIMALS; CYTOKINES; LEECHES; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 2442445062     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043384358     Document Type: Review

References (69)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
2. Bischoff J. Cell adhesion and angiogenesis. J Clin Invest 1997; 100: 37-9.
3. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumour growth. Cell 1997; 88, 277-285.
4. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumour growth. Cell 1997; 88: 277-85.
5. Gibaldi M. Regulatory angiogenesis: a new therapeutic strategy. J Clin Pharmacol 1998; 38: 898-903.
6. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6: 389-395.
7. Collins MK, Perkins GR, Rodriguez-Tarduchy G, Nieto MA, Lopez-Rivas A. Growth factors as survival factors: regulation of apoptosis. Bioessays 1994; 16: 133-8.
8. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 1987; 237: 1333-6.
9. Cross M, Dexter TM. Growth factors in development, transformation, and tumourigenesis. Cell 1991: 64: 271-80.
10. Kresse H, Schonherr E. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 2001; 189: 266-74.
11. Staal FJ, Ela SW, Roederer M, Anderson MT, Herzenberg LA, Herzenberg LA. Glutathione deficiency and human immunodeficiency virus infection. Lancet 1992; 339: 909-12.
12. Ottaviani E, Barbieri D, Franchim A, Kletsas D. PDGF and TGF-beta partially prevent 2-deoxy-D-ribose-induced apoptosis in the fat body cell line IPLB-LdFB from the insect Lymantria dispar. J Insect Physiol 20W 46: 81-7.
13. Ottaviani E, Barbieri D, Malagoli D, Kletsas D. Involvement of PI 3-kinase, PKA and PKC in PDGF- and TGF-beta-mediated prevention of 2-deoxy-D-ribose-induced apoptosis in tile insect cell line, IPLB-LdFB. Cell Biol Int 2001; 25: 171-7.
14. Franchini A, Ottaviani E. Repair of molluscan tissue injury: role of PDGF and TGF-beta1. Tissue Cell 2000; 32: 312-21.
15. Stefano GB, Smith EM, Hughes TK. Opioid induction of immunoreactive interleukin-1 in Mytilus edulis and human immunocytes an interleukin-1-like substance in invertebrate neural tissue. J Neuroimmunol 1991; 32: 29-34.
16. Hughes TK Jr, Smith EM, Barnett JA, Charles R, Stefano GB. LPS stimulated invertebrate hemocytes: a role for immunoreactive TNF and IL-1. Dev Comp Immunol 1991; 15: 117-22.
17. Ottaviani E, Malagoli D, Franchini A. Invertebrate humoural factors: cytokines as mediators of cell survival. Prog Mol Subcell Biol 2003; 34: 1-25.
18. Jiang WG, Harding KG. Enhancement of wound tissue expansion and angiogenesis by matrix-embedded fibroblast (dermagraft), a role of hepatocyte growth factor/scatter factor. Int J Mol Med 1998; 2: 203-10.
19. Salven P, Lymboussaki A, Heikkila P, Jaaskela-Saari H, Enholm B, Aase K, et al. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumours. Am J Pathol 1998; 153: 103-8.
20. Aggarwal BB, Puri RK. Human cytokines: their role in disease therapy. USA, Blackwell Science 1995.
21. Rosenstein JM, Mani N, Silverman WF, Krum JM, Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA 1998; 95: 7086-91.
22. Jih YJ, Lien WH, Tsai WC, Yang GW, Li C, Wu LW. Distinct regulation of genes by bFGF and VEGF-A in endothelial cells. Angiogenesis 2001; 4: 313-321.
23. Phillips GD, Whitehead RA, Stone AM, Ruebel MW, Goodkin ML, Knighton DR. Transforming growth factor beta (TGF-B) stimulation of angiogenesis: an electron microscopic study. J Submicrose Cytol Pathol 1993; 25: 149-55.
24. Ottaviani E, Franchini A, Kletsas D Plaelet-derived growth factor and transforming growth factor-beta in invertebrate immune and neuroendocrine interactions: another sign of conservation in evolution. Comp Biochem Physiol C Toxicol Pharmacol 2001; 129: 295-306.
25. Haralson MA, DiMari SJ, Hoover RL, Harris RC. Effects of epidermal growth factor oil collagen expression by rat kidney mesangial cells in culture. Matrix Biol 2000, 19: 47-59.
26. Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJ, et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989; 337: 471-3.
27. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-39.
28. Yancopoulos GD, Davis S, Gale NW, Ridge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation, Nature 2000, 407: 242-8.
29. Zachary I, Gliki G. Signalling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 2001; 49: 568-91.
30. Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem Soc Trans 2003; 31: 20-24.
31. Cho NK, Keyes L, Johnson F, Heller J, Ryner L, Karim F, et al. Developmental control of blood cell migration by the Drosophila VEGF pathway. Cell 2002; 108: 865-76.
32. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors, Nat Med 2003; 9: 669-76.
33. Clauss M. Molecular biology of the VEGF and the VEGF receptor family. Semin Thromb Hemost 2000; 26: 561-9.
34. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13: 9-22.
35. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumours. Mol Biol Cell 1992; 3: 211-20.
36. Breier G, Clauss M, Risau W. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev Dyn 1995; 204: 228-39.
37. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376: 62-6.
38. Fong GH, Rossant J, Gertsenstein M Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376: 66-70.
39. Beschin A, Bilej M, Torreele F, De Baetselier P. On the existence of cytokines in invertebrates. Cell. Mol. Life Sci. 2001, 58: 801-14.
40. Beck G, Habicht GS Invertebrate cytokines. Ann NY Acad Sci 1994; 712: 206-12.
41. Bilej M, Brys L, Beschin A, Lucas R, Vercauteren E, Hanusova R, et al. Identification of a cytolytic protein in the coelomic fluid of Eisenia foetida earthworms. Immunol Lett 1995; 45: 123-8.
42. Duchek P, Somogyi K, Jekely G, Beccari S, Rorth P. Guidance of cell migration by the Drosophila PDGF/VEGF receptor. Cell 2001, 107: 17-26.
43. Heino TI, Karpanen T, Wahlstrom G, Pulkkinen M, Eriksson U, Alitalo K, et al. The Drosophila VEGF receptor homologue is expressed in haemocytes. Mech Dev 2001; 109: 69-77.
44. de Eguileor M, Tettamanti G, Grimaldi A, Congiu T, Ferrarese R, Perletti G, et al. Leeches: immune response, angiogenesis and biomedical applications. Curr Pharm Des 2003, 9: 133-47.
45. de Eguileor M, Grimaldi A, Tettamanti G, Ferrarese R, Congiu T, Protasoni M, et al. Hirudo medicinalis: a new model for testing activators and inhibitors of angiogenesis. Angiogenesis 2001, 4: 299-312.
46. Tettamanti G, Grimaldi A, Valvassori R, Rinaldi L, de Eguileor M. Vascular endothelial growth factor is involved in neoangiogenesis in Hirudo medicinalis (Annelida, Hirudinea). Cytokine 2003, 22: 168-79.
47. Tettamanti G, Grimaldi A, Ferrarese R, Palazzi M, Perletti G, Valvassori R, et al. Leech responses to tissue transplantation. Tissue Cell 2003; 35: 199-212.
48. de Eguileor M, Grimaldi A, Tettamanti G, Valvassori R, Cooper EL, Lanzavecchia G. Lipopolysaccharide-dependent induction of leech leukocytes that cross-react with vertebrate cellular differentiation markers. Tissue Cell 2000, 32: 437-45.
49. de Eguileor M, Tettamanti G, Grimaldi A, Boselli A, Scari G, Valvassori R, et al. Histopathological changes after induced injury in leeches. J Invertebr Pathol 1999; 74: 14-28.
50. de Eguileor M, Grimaldi A, Tettamanti G, Valvassori R, Cooper EL, Lanzavecchia G. Different types of response to foreign antigens by leech leukocytes. Tissue Cell 2000; 32: 40-8.
51. Sawyer RT. Leech biology and behaviour: anatomy, physiology and behaviour. Oxford, Oxford Science Publications, 1986.
52. de Eguileor M, Grimaldi A, Tettamanti G, Congiu T, Protasoni M, Reguzzoni M, et al. Ultrastructure and functional versatility of hirudinean botryoidal tissue. Tissue Cell 2001; 33: 332-41.
53. Huguet G, Molinas M. The pseudoblastema in the wound healing process of the leech Hirudo medicinalis L. (Hirudinea): changes in cell junctions. J Exp Zool 1994, 269: 23-36.
54. Fischer E. The myelo-erythroid nature of the chloragogenous-like tissues of the annelids. Comp Biochem Physiol 1993; 106A: 449- 53.
55. Moulin V. Growth factors in skin wound healing. Eur J Cell Biol 1995; 68, 1-7.
56. Leung DW, Cachianes G, Kuang WJ, Goeddel DV. Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989: 246: 1306-9.
57. Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, et al. Utilisation of distinct signalling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem 2000; 275: 5096-103.
58. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 1995: 7: 619-27.
59. Garnier-Raveaud S, Usson Y, Cand F, Robert-Nicoud M, Verdetti J, Faury G. Identification of membrane calcium channels essential for cytoplasmic and nuclear calcium elevations induced by vascular endothelial growth factor in human endothelial cells. Growth Factors 2001, 19: 35-48.
60. Morales-Ruiz M, Fulton D, Sewa G, Languino LR, Fujio Y, Walsh K, et al. Vascular endothelial growth factor-stimulated actin reorganisation and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res 2000; 86: 892-6.
61. Franchini A, Kletsas D, Ottaviani E. Immunocytochemicai evidence of PDGF-and TGF-beta-like molecules in invertebrate and vertebrate immunocytes: an evolutionary approach. Histochem J 1996; 28: 599-605.
62. Yla-Herttuala S, Alitalo K. Gene transfers as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694-701.
63. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, et al. Constitutive expression of ph VEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischaemia. Circulation 1998; 97: 1114-23.
64. Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vase Surg 1998; 28: 964-73.
65. Vale PR, Losordo DW, Milliken CE, Maysky M, Esakof DD, Symes JF, et al. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischaemia. Circulation 2000; 102: 965-74.
66. Perletti G, Marras E, Dondi D, Grimaldi A, Tettamanti G, Valvassori R, et al. Assessment of the biological activity of an improved naked-DNA vector for angiogenesis gene therapy on a novel hirudinean model. Int J Mol Med 2003; 11: 691-6.
67. de Eguileor M, Tettamanti G, Grimaldi A, Congiu T, Ferrarese R, Perletti G, et al. Leeches: immune response, angiogenesis and biomedical applications. Curr Pharm Design 2003; 9(2): 133-47.
68. Kiefer FN, Neysari S. Humar R, Li W, Munk VC, Battegay EJ. Hypertension and angiogenesis, Curr Pharm Design 2003; 9(21): 1733-44.
69. Schratzberger P, Kirchmair R, Vale PR, Losordo DW. Therapeutic angiogenesis by gene transfer in critical limb and myocardial ischemia. Curr Pharm Design 2003, 9(13): 1041-7.